Skip to content

One Dollar Incentive to Improve Tuberculosis Treatment Outcomes in a Programmatic Setting (ODITOPS trial)

One Dollar Incentive to Improve Tuberculosis Treatment Outcomes in a Programmatic Setting (ODITOPS trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201908538333264
Enrollment
405
Registered
2019-08-14
Start date
2018-11-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

One dollar financial incentive
Routine Care
Restrospective Group

Sponsors

Mount Kenya University Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients of 18 years and above 2. Evidence of a personally signed and dated informed consent document. 3. All TB patients at initiation of treatment at the participating sites will be included in the study (bacteriologically confirmed TB, clinically diagnosed and extra pulmonary TB)

Exclusion criteria

Exclusion criteria: 1. Patients with CNS TB or TB requiring treatment for more than 6 months 2. Also all patients with documented drug resistant TB will be excluded because their treatment duration is longer than six months and they receive food and financial incentives at the site in Uganda.

Design outcomes

Primary

MeasureTime frame
TB treatment success defined as the total number of patients in the study arm documented in the TB register as having cured or completed treatment divided by the total number of patients in that study arm. ;TB loss to follow up rate as defined by the total number of TB patients in the study arm documented in the TB register as loss to follow up divided by the total number of patients in that study arm.

Secondary

MeasureTime frame
TB death defined as the total number of patients in the study arm documented in the TB register as having died divided by the total number of patients in that study arm.;TB treatment failure defined as the total number of patients in the study arm documented in the TB register as a treatment failure divided by the total number of patients in that study arm.

Countries

Kenya, Uganda

Contacts

Public ContactJoseph Muchiri

Lecturer Mount Kenya University

jmuchiri@mku.ac.ke254719802082

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026